Acrivon AB
Agent40Agent Readiness: 40/100. Below median. Measured by StartupHub.ai. Median 41.Trust87Data Trust: 87/100. Top 25%. Measured by StartupHub.ai. Median 61.Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. This platform uncovers drug sensitivity not achievable through genomics, enabling them to improve patient outcomes with their pipeline programs, including ACR-368, ACR-2316, and ACR-6840.
About
Acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. This platform uncovers drug sensitivity not achievable through genomics, enabling them to improve patient outcomes with their pipeline programs, including ACR-368, ACR-2316, and ACR-6840. Acrivon also partners with other companies to develop predictive OncoSignature tests for drug candidates.
Listed competitors
Also in this space
Warp is an open platform for building software with agents. Build cloud software factories with Oz, and build locally with Warp’s open source agentic terminal. Free to start.
Shares AI Tools & Apps, AI Drug Discovery
AI-powered research assistant for scientific literature review and data extraction.
Shares Foundation Model, AI Drug Discovery
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Drug Discovery, Therapeutics
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares HealthTech, Biotech
Shares AI Tools & Apps, Biotech
Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Shares Drug Discovery, Biotech
Key facts
- Website
- acrivon.com
- Headquarters
- Uppsala, Sweden
- Founded
- 2022
- Total funding
- $10M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 16 May 2023 | Seed | $10M | Eir Ventures |
Tech stack
Detected on acrivon.com, last scanned 29 Oct 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- React
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Mimecast
Acrivon AB scores 31. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Acrivon AB trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Acrivon AB is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Acrivon AB raised?
Acrivon AB has raised a total of $10M in funding. The most recent round on record is Seed.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Acrivon AB
